Results 221 to 230 of about 37,073 (238)

Hormonal Receptor Status Determines Prognostic Significance of FGFR2 in Invasive Breast Carcinoma

Cancers, 2020
Dominika Piasecka, Bartlomiej Tomasik, Hanna Romanska-Knight   +2 more
exaly  

Anti-FGFR2 antibodies

2013
WENG ZHIGANG, WINSTON WILLIAM M JR, BAI AILIN, MEETZE KRISTAN, WEILER SOLLY, CHEN TING, GYURIS JENO   +6 more
openaire   +2 more sources

Sox2 Induction by FGF and FGFR2 Activating Mutations Inhibits Wnt Signaling and Osteoblast Differentiation

Journal of Cell Biology, 2005
Greg Holmes, Alka Mansukhani, Claudio Basilico   +2 more
exaly  

DETECTION OF FGFR2

2016
YOSHIMURA CHIGUSA, KAWAIDA REIMI, HONDA KOKICHI   +2 more
openaire   +2 more sources

FGFR2 Overexpression Predicts Survival Outcome in Patients With Metastatic Papillary Renal Cell Carcinoma

Clinical and Translational Oncology, 2017
Dmitry Khochenkov, Ilya Tsimafeyeu, L Demidov   +2 more
exaly  

A FGFR2 Inhibitor, Ki23057, Enhances the Chemosensitivity of Drug-Resistant Gastric Cancer Cells

Cancer Letters, 2011
Xiaotian Zhang, Masakazu Yashiro, Kōsei Hirakawa   +2 more
exaly  

Discovery of Lirafugratinib (RLY-4008), a Highly Selective Irreversible Small-Molecule Inhibitor of FGFR2

Proceedings of the National Academy of Sciences of the United States of America
Barry Touré, David E. Shaw, Pelin Ayaz
exaly  

Conditional Gene Inactivation Reveals Roles for Fgf10 and Fgfr2 in Establishing a Normal Pattern of Epithelial Branching in the Mouse Lung

Developmental Dynamics, 2009
Suzanne L. Mansour, Lisa L Abler
exaly  

Discovery of LHQ490 as a Highly Selective Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitor

European Journal of Medicinal Chemistry
Zhen Wang, Ke Ding, Chen Su
exaly  

Discovery of BW710 as a Potent, Selective and Orally Bioavailable Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitor

European Journal of Medicinal Chemistry
Zhen Wang, Ke Ding, Dawei Ma
exaly